FDA.reportPublic FDA data

Phyrago 20 MG Oral Tablet

RxCUI
2691841
RxNorm name
Phyrago 20 MG Oral Tablet
Display name
Phyrago 20 MG Oral Tablet
Full name
Phyrago 20 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
60976d1e-c415-417f-8168-4e07999a7281PHYRAGO 20 MG Oral Tablet [PSN] · dasatinib 20 MG Oral Tablet [Phyrago] [SBD] · Phyrago 20 MG Oral Tablet [SY]33These highlights do not include all the information needed to use PHYRAGO safely and effectively. See full prescribing information for PHYRAGO. PHYRAGO TM (dasatinib) tablets, for oral use Initial U.S. Approval: 200620250823